Highlights

  • Zydus Cadila's ZyCoV-D approved for children above 12 years old
  • Covaxin being reviewed for children above 2 years
  • India reported 21 cases of Omicron variant of Covid

Latest news

Future Netwings Solution Enhances Service Delivery with the Business Continuity Policy

Future Netwings Solution Enhances Service Delivery with the Business Continuity Policy

India-UK trade deal likely by May 1; Europe deal expected by year-end

India-UK trade deal likely by May 1; Europe deal expected by year-end

VerSe Innovation Appoints Prasanna Prasad as Chief Product and Technology Officer to Accelerate AI-Led Product and Platform Innovation

VerSe Innovation Appoints Prasanna Prasad as Chief Product and Technology Officer to Accelerate AI-Led Product and Platform Innovation

Changing Aspirations of Premium Homebuyers in NCR

Changing Aspirations of Premium Homebuyers in NCR

Airfloa Rail Technology's FY26 Business Update and Strategic Direction

Airfloa Rail Technology's FY26 Business Update and Strategic Direction

Sanjay Khanna Appointed as Chairman & Managing Director of BPCL

Sanjay Khanna Appointed as Chairman & Managing Director of BPCL

Galgotias University Placement Report: 4700+ Offers Across Top Recruiters in 2026

Galgotias University Placement Report: 4700+ Offers Across Top Recruiters in 2026

"Be the same loving brother you are to me...": Sanjay Dutt pens heartfelt birthday note for Anant Ambani

"Be the same loving brother you are to me...": Sanjay Dutt pens heartfelt birthday note for Anant Ambani

Stock in focus: Cadila Health, Kid vaccination roll-out to be announced for Zycov-D

The Covid-19 advisory group in India will meet today to discuss vaccination for children alongside other issues like booster dose.

Stock in focus: Cadila Health, Kid vaccination roll-out to be announced for Zycov-D

Zydus Cadila will be in focus today as an announcement for children vaccination is expected today.The stock which hit a high of Rs 668/share in July end has been reeling under pressure since due to the lack of clarity on the kid vaccine rollout.

As of now, only Zydus Cadila's ZyCoV-D has been approved for emergency use in India for children above 12 years old.

The National Technical Advisory Group on Immunisation (NTAGI), the Covid-19 advisory group in India, will meet today to discuss vaccination for children, alongside other issues like booster dose.

This comes as India reported 17 more cases of Omicron variant of Covid-19 on Sunday, taking the tally to 21.

ADVERTISEMENT

Up Next

Stock in focus: Cadila Health, Kid vaccination roll-out to be announced for Zycov-D

Stock in focus: Cadila Health, Kid vaccination roll-out to be announced for Zycov-D

Centre plans to borrow Rs 8.20 lakh cr from market in first half of FY27

Centre plans to borrow Rs 8.20 lakh cr from market in first half of FY27

Reliance denies buying Iranian oil amid US sanctions waiver

Reliance denies buying Iranian oil amid US sanctions waiver

Premium petrol price up Rs 2, industrial diesel up Rs 22; no change in normal petrol, diesel rates

Premium petrol price up Rs 2, industrial diesel up Rs 22; no change in normal petrol, diesel rates

India's GDP expected to register over 8 pc growth in Sep-Dec: Report

India's GDP expected to register over 8 pc growth in Sep-Dec: Report

Govt announces seven measures to help boost exports

Govt announces seven measures to help boost exports

ADVERTISEMENT

editorji-whatsApp

More videos

RBI keeps interest rates on hold after US trade deal boosts outlook

RBI keeps interest rates on hold after US trade deal boosts outlook

RBI proposes to compensate customers up to Rs 25,000 loss due to fraud

RBI proposes to compensate customers up to Rs 25,000 loss due to fraud

RBI raises GDP growth projection of Q1, Q2 of FY27

RBI raises GDP growth projection of Q1, Q2 of FY27

RBI pauses rate cuts, retains interest rate at 5.25 pc

RBI pauses rate cuts, retains interest rate at 5.25 pc

Rupee jumps 122 paise to close at 90.27 against US dollar on India-US trade deal

Rupee jumps 122 paise to close at 90.27 against US dollar on India-US trade deal

Stock markets cheer India-US trade deal: Sensex, Nifty surge 2.5 pc

Stock markets cheer India-US trade deal: Sensex, Nifty surge 2.5 pc

UPI transactions hit record high of Rs 230 lakh crore in 2025-26 till Dec: Govt

UPI transactions hit record high of Rs 230 lakh crore in 2025-26 till Dec: Govt

Explained: India-US trade deal, tariffs and trade benefits

Explained: India-US trade deal, tariffs and trade benefits

Trade deal with US adds momentum to India's growth ambition: Industry leaders

Trade deal with US adds momentum to India's growth ambition: Industry leaders

Rupee jumps 119 paise to 90.30 against the US dollar on India-US trade deal

Rupee jumps 119 paise to 90.30 against the US dollar on India-US trade deal

Editorji Technologies Pvt. Ltd. © 2022 All Rights Reserved.